BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2020563)

  • 21. An A to T transversion at position -5 of the factor IX promoter results in hemophilia B.
    Picketts DJ; D'Souza C; Bridge PJ; Lillicrap D
    Genomics; 1992 Jan; 12(1):161-3. PubMed ID: 1733855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Twenty-four novel hemophilia B mutations revealed by rapid scanning of the whole factor IX gene in a French population sample.
    Ghanem N; Costes B; Martin J; Vidaud M; Rothschild C; Foyer-Gazengel C; Goossens M
    Eur J Hum Genet; 1993; 1(2):144-55. PubMed ID: 8055323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Five novel factor IX mutations in unrelated hemophilia B families.
    Chen SH; Schoof JM; Scott CR; Thompson AR
    Hum Mol Genet; 1993 May; 2(5):599-600. PubMed ID: 8518801
    [No Abstract]   [Full Text] [Related]  

  • 24. Screening for mutations in the gene encoding factor IX.
    Nielsen LR; Schwartz M; Scheibel E
    J Inherit Metab Dis; 1992; 15(3):339-41. PubMed ID: 1357229
    [No Abstract]   [Full Text] [Related]  

  • 25. Usual and unusual mutations in a cohort of Belgian patients with hemophilia B.
    Lannoy N; Lambert C; Farrugia A; Van Damme A; Hermans C
    Thromb Res; 2017 Jan; 149():25-28. PubMed ID: 27865967
    [No Abstract]   [Full Text] [Related]  

  • 26. T296----M, a common mutation causing mild hemophilia B in the Amish and others: founder effect, variability in factor IX activity assays, and rapid carrier detection.
    Ketterling RP; Bottema CD; Koeberl DD; Ii S; Sommer SS
    Hum Genet; 1991 Jul; 87(3):333-7. PubMed ID: 1864609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deep intronic mutations are rarely a cause of hemophilia B.
    Feng J; Liu Q; Drost J; Sommer SS
    Hum Mutat; 1999; 14(3):267-8. PubMed ID: 10477436
    [No Abstract]   [Full Text] [Related]  

  • 28. [Four novel point mutations of factor IX gene detected by denaturing gradient gel electrophoresis].
    Wang Y; Li Z; Wan H
    Zhonghua Xue Ye Xue Za Zhi; 1998 Mar; 19(3):125-8. PubMed ID: 11243142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factor IXPortland: a nonsense mutation (CGA to TGA) resulting in hemophilia B.
    Chen SH; Scott CR; Schoof J; Lovrien EW; Kurachi K
    Am J Hum Genet; 1989 Apr; 44(4):567-9. PubMed ID: 2929599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A new polymorphism in the human factor IX gene, useful for determining carriers of hemophilia B].
    Surin VL; Luk'ianenko AV; Tagiev AF; Smirnova OV
    Genetika; 1994 Jun; 30(6):740-2. PubMed ID: 7958786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Haemophilia B caused by mutation of a potential thrombin cleavage site in factor IX.
    Winship PR
    Nucleic Acids Res; 1990 Mar; 18(5):1310. PubMed ID: 2320433
    [No Abstract]   [Full Text] [Related]  

  • 32. CG dinucleotide transitions in the factor IX gene account for about half of the point mutations in hemophilia B patients: a Seattle series.
    Chen SH; Zhang M; Lovrien EW; Scott CR; Thompson AR
    Hum Genet; 1991 Jun; 87(2):177-82. PubMed ID: 2066105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombination between two 14-bp homologous sequences as the mechanism for gene deletion in factor IX Seattle 1.
    Chen SH; Scott CR
    Am J Hum Genet; 1990 Dec; 47(6):1020-2. PubMed ID: 2239965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Coagulation factor IX gene mutations of ten patients with hemophilia B].
    Jiang XW; Wei HY; Liu Z
    Zhonghua Xue Ye Xue Za Zhi; 2013 Mar; 34(3):259-61. PubMed ID: 23683429
    [No Abstract]   [Full Text] [Related]  

  • 35. Factor IX New London: substitution of proline for glutamine at position 50 causes severe hemophilia B.
    Lozier JN; Monroe DM; Stanfield-Oakley S; Lin SW; Smith KJ; Roberts HR; High KA
    Blood; 1990 Mar; 75(5):1097-104. PubMed ID: 2306516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recurrent nonsense mutations at arginine residues cause severe hemophilia B in unrelated hemophiliacs.
    Koeberl DD; Bottema CD; Sarkar G; Ketterling RP; Chen SH; Sommer SS
    Hum Genet; 1990 Apr; 84(5):387-90. PubMed ID: 1969838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Three distinct point mutations in the factor IX gene of three Japanese CRM+ hemophilia B patients (factor IX BMNagoya 2, factor IX Nagoya 3 and 4).
    Hamaguchi M; Matsushita T; Tanimoto M; Takahashi I; Yamamoto K; Sugiura I; Takamatsu J; Ogata K; Kamiya T; Saito H
    Thromb Haemost; 1991 May; 65(5):514-20. PubMed ID: 1871712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factor IX Chongqing: a new mutation in the calcium-binding domain of factor IX resulting in severe hemophilia B.
    Wang NS; Zhang M; Thompson AR; Chen SH
    Thromb Haemost; 1990 Feb; 63(1):24-6. PubMed ID: 2339358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Consequences of factor IX mutations in 26 families with haemophilia B.
    Weinmann AF; Murphy ME; Thompson AR
    Br J Haematol; 1998 Jan; 100(1):58-61. PubMed ID: 9450791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Three point mutations in the factor IX genes of five hemophilia B patients. Identification strategy using localization by altered epitopes in their hemophilic proteins.
    Chen SH; Thompson AR; Zhang M; Scott CR
    J Clin Invest; 1989 Jul; 84(1):113-8. PubMed ID: 2472424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.